Histological study on mast cells in conjunctiva of NC/Nga mice

Japanese Journal of Ophthalmology

Volumn 48, Issue 3, 2004, Pages 189-194

  Inada, Noriko ^a   Shoji, Jun ^a   Tabuchi, Kyoko ^a   Saito, Keiko ^a   Sawa, Mitsuru ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Atopic keratoconjunctivitis; Histopathological study; Mast cell density; NC Nga mice

Indexed keywords

DEXAMETHASONE; TACROLIMUS;

AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOPIC DERMATITIS; CELL DENSITY; CONJUNCTIVA; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; EYELID; HISTOLOGY; KERATOCONJUNCTIVITIS; MAST CELL; MICROSCOPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN; SYMPTOM; TISSUE SECTION;

AGING; ANIMALS; CELL COUNT; CONJUNCTIVA; DERMATITIS, ATOPIC; DEXAMETHASONE; GLUCOCORTICOIDS; IMMUNOSUPPRESSIVE AGENTS; MAST CELLS; MICE; MICE, INBRED STRAINS; TACROLIMUS;

EID: 2542470815     PISSN: 00215155     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10384-003-0048-5     Document Type: Article

References (19)

1. Matsuda H, Watanabe N, Geba GP, et al. Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. Int Immunol 1997;9:461-466.
2. Suto H, Matsuda H, Mitsuishi K, et al. NC/Nga mice: a mouse model for atopic dermatitis. Int Arch Allergy Immunol 1999;120:170-175.
3. TC in vernal conjunctivitis and giant papillary conjunctivitis. J Allergy Clin Immunol 1990;86:34-40.
4. Morgan SJ, Williams JH, Walls AF, Church MK, Holgate ST, McGill JI. Mast cell numbers and staining characteristics in the normal and allergic human conjunctiva. J Allergy Clin Immunol 1991;87:111-116.
5. Baddeley SM, Bacon AS, McGill JI, Lightman SL, Holgate St, Roche WR. Mast cell distribution and neutral protease expression in acute and chronic allergic conjunctivitis. Clin Exp Allergy 1995;25:41-50.
6. Tuft SJ, Cree IA, Woods M, Yorston D. Limbal vernal keratoconjunctivitis in the tropics. Ophthalmology 1988;105:1489-1493.
7. Morgan SJ, Williams JH, Walls AF, Holgate ST. Mast cell hyperplasia in atopic keratoconjunctivitis. Eye 1991;2:729-735.
8. BenEzra D, Pe'er J, Brodsky M, Cohen E. Cyclosporine eyedrops for the treatment of severe vernal keratoconjunctivitis. Am J Ophthalmol 1986;101:278-282.
9. Secchi A, Tognon M, Leonardi A. Topical use of cyclosporine in the treatment of vernal keratoconjunctivitis. Am J Ophthalmol 1990;110:641-645.
10. Bleik JH, Tabbara KE Topical cyclosporine in vernal keratoconjunctivitis. Ophthalmology 1991;98:1679-1684.
11. Tomita K, Merino G, Tsuru T, Fujino Y. Topical cyclosporine treatment for intractable vernal keratoconjunctivitis and atopic keratoconjunctivitis. Atarashii Ganka (J Eye) 1994;11:1241-1243.
12. Iwamoto H, Yoshida H, Yoshida O, Fukushima A, Ueno H. Inhibitory effects of FK506 on the development of experimental allergic/immune-mediated blepharoconjunctivitis in Lewis rats by systemic but not by topical administration. Graefes Arch Clin Exp Ophthalmol 1999;237:407-414.
13. Foster CS, Rice BA, Dutt JE. Immunopathology of atopic keratoconjunctivitis. Ophthalmology 1991;98:1190-1196.
14. Otsuka H, Denburg J, Dolovich J, et al. Heterogeneity of metachromatic cells in human nose: significance of mucosal mast cells. J Allergy Clin Immunol 1985;76:695-702.
15. Irani AA, Schechter NM, Craig S, et al. Two types of human mast cell that have distinct neutral protease compositions. Proc Natl Acad Sci U S A 1986;83:4464-4468.
16. King SJ, Miller HRP, Newlands GFJ, Woodbury RG. Depletion of mucosal mast cell protease by corticosteroids: effect on intestinal anaphylaxis in the rat. Proc Natl Acad Sci U S A 1985;82:1214-1218.
17. Goldsmith P, McGarity B, Walls AF, et al. Corticosteroid treatment reduces mast cell numbers in inflammatory bowel disease. Dig Dis Sci 1990;35:1409-1413.
18. Soda K, Kawabori S, Kanai N, Bienenstock J, Perdue MH. Steroid-induced depletion of mucosal mast cells and eosinophils in intestine of athymic nude rats. Int Arch Allergy Immunol 1993;101:39-46.
19. Ito F, Toyota N, Sakai H, Takahashi H, Iizuka H. FK506 and cyclosporin A inhibit stem cell factor-dependent cell proliferation/survival, while inducing upregulation of c-kit expression in cells of the mast cell line MC/9. Arch Dermatol Res 1999;291:275-283.